Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 1.1.99.24 - hydroxyacid-oxoacid transhydrogenase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenoma
Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.
Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma.
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.
alcohol dehydrogenase deficiency
D-2-hydroxyglutaric aciduria in three patients with proven SSADH deficiency: genetic coincidence or a related biochemical epiphenomenon?
Breast Neoplasms
ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming.
ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer.
Biochemical Background in Mitochondria Affects 2HG Production by IDH2 and ADHFE1 in Breast Carcinoma.
Carcinogenesis
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer.
Carcinoma
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.
Colonic Neoplasms
Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.
Colorectal Neoplasms
Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.
Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells.
Hypermethylation Of ADHFE1 Promotes The Proliferation Of Colorectal Cancer Cell Via Modulating Cell Cycle Progression.
Insulin Resistance
A genome scan for positive selection in thoroughbred horses.
Mouth Neoplasms
MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer.
Neoplasms
ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming.
ADHFE1 is a correlative factor of patient survival in cancer.
Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma.
Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma.
Stomach Neoplasms
ADHFE1 is a correlative factor of patient survival in cancer.
Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.